Acta Cardiologica 2006-12-01

Celiprolol-induced lupus-like syndrome.

Jean-Christophe Charniot, Thierry Genereau, Luc Mouthon

Index: Acta Cardiol. 61(6) , 661-3, (2006)

Full Text: HTML

Abstract

Systemic lupus erythematosus can be idiopathic or drug-induced. Although a number of beta-blockers have been reported to induce a lupus-like syndrome, to the best of our knowledge, no such case has been described following celiprolol therapy. We diagnosed a lupus-like syndrome in a 67-year-old female patient who developed febrile polyarthritis, percarditis, antinuclear and anti-histone antibodies after taking celiprolol for 2 years. Despite drug withdrawal, prolonged corticotherapy was needed to obtain clinical and biological remission.


Related Compounds

Related Articles:

Highly sensitive transient isotachophoresis sample stacking coupling with capillary electrophoresis-amperometric detection for analysis of doping substances

2010-01-01

[Talanta 81(4-5) , 1288-94, (2010)]

Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis.

2008-06-01

[Electrophoresis 29(11) , 2321-9, (2008)]

Direct determination of celiprolol in human urine using on-line coupled ITP-CZE method with fiber-based DAD.

2008-11-01

[Electrophoresis 29(22) , 4561-7, (2008)]

Celiprolol, a selective beta1-blocker, reduces the infarct size through production of nitric oxide in a rabbit model of myocardial infarction.

2007-04-01

[Circ. J. 71(4) , 574-9, (2007)]

Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats.

2013-01-01

[Drug Metab. Pharmacokinet. 28(4) , 356-61, (2013)]

More Articles...